Loading...

Herbalife Nutrition Ltd.

HLFNYSE
Consumer Defensive
Packaged Foods
$9.74
$0.56(6.10%)

Herbalife Nutrition Ltd. (HLF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Herbalife Nutrition Ltd. (HLF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
-1.37%
1.37%
Operating Income Growth
8.28%
8.28%
Net Income Growth
78.83%
78.83%
Operating Cash Flow Growth
-20.17%
20.17%
Operating Margin
9.92%
9.92%
Gross Margin
78.12%
78.12%
Net Profit Margin
6.59%
6.59%
ROE
-41.25%
41.25%
ROIC
29.78%
29.78%

Herbalife Nutrition Ltd. (HLF) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Herbalife Nutrition Ltd. HLF financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$1.22B$1.21B$1.24B$1.28B
Cost of Revenue$265.20M$267.50M$268.70M$317.20M
Gross Profit$956.50M$939.90M$971.60M$963.90M
Gross Profit Ratio$0.78$0.78$0.78$0.75
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$431.90M$436.90M$444.00M$870.70M
Operating Expenses$833.70M$856.90M$807.30M$870.70M
Total Costs & Expenses$1.10B$1.10B$1.11B$1.19B
Interest Income$2.60M$3.00M$2.90M$2.70M
Interest Expense$54.60M$56.90M$59.40M$60.40M
Depreciation & Amortization$30.70M$29.00M$30.60M$32.60M
EBITDA$156.10M$138.50M$160.60M$105.20M
EBITDA Ratio$0.13$0.11$0.13$0.08
Operating Income$122.80M$106.50M$127.10M$93.20M
Operating Income Ratio$0.10$0.09$0.10$0.07
Other Income/Expenses (Net)-$52.00M-$53.90M-$56.50M-$68.20M
Income Before Tax$70.80M$52.60M$70.60M$12.20M
Income Before Tax Ratio$0.06$0.04$0.06$0.010
Income Tax Expense$20.40M-$125.30M$23.20M$7.50M
Net Income$50.40M$177.90M$47.40M$4.70M
Net Income Ratio$0.04$0.15$0.04$0.004
EPS$0.50$1.76$0.47$0.05
Diluted EPS$0.49$1.74$0.47$0.05
Weighted Avg Shares Outstanding$101.50M$101.10M$100.90M$100.60M
Weighted Avg Shares Outstanding (Diluted)$102.20M$102.00M$101.90M$101.70M

Over the past four quarters, Herbalife Nutrition Ltd. demonstrated steady revenue growth, increasing from $1.28B in Q2 2024 to $1.22B in Q1 2025. Operating income reached $122.80M in Q1 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $156.10M, reflecting operational efficiency. Net income dropped to $50.40M, with EPS at $0.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;